Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients

Status Terminated

Clinical Trial Summary

Children with levothyroxine (T21) have developmental delay and other functional gastrointestinal (GI) issues that may negatively affect L-T4 tolerability and absorption. For an age group unable to swallow tablets whole by mouth, tablets must be crushed and suspended in water, breast milk or formula for administration in order to treat children with hypothyroidism. For this age group, ease of administration may have a significant impact on compliance and ability to remain euthyroid. We propose that Tirosint-SOL® will be more favorably received due to ease of administration, improved tolerability and palatability, therefore leading to improved adherence when compared to L-T4 tablets.

Clinical Trial Description

Hypothyroidism is a common medical disorder in children with Trisomy 21 (T21). Treatment with oral tablet levothyroxine (L-T4) is primarily used to treat this condition. However, children with T21 have developmental delay and other functional gastrointestinal (GI) issues that may negatively affect L-T4 tolerability and absorption. For an age group unable to swallow tablets whole by mouth, tablets must be crushed and suspended in water, breast milk or formula for administration in order to treat children with hypothyroidism. For this age group, ease of administration may have a significant impact on compliance and ability to remain euthyroid. Until recently, there was no liquid preparation of L-T4 in the United States for use in children. Tirosint-SOL® (liquid stable L-T4) is now FDA-approved for use in children. The Investigator proposes that Tirosint-SOL® will be more favorably received due to ease of administration, improved tolerability and palatability, therefore leading to improved adherence when compared to L-T4 tablets. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04747275
Study type	Interventional
Source	Children's Mercy Hospital Kansas City
Contact
Status	Terminated
Phase	Phase 4
Start date	January 18, 2021
Completion date	November 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05975866` - The Effects of an Anti-inflammatory Diet With or Without Curcumin Supplementation on Anthropometric Measurements, Concentrations of Thyroid Hormones, Anti-TPO, and Systemic Inflammation in Plasma and NFK-B in Peripheral Blood Mononuclear Cells in Patients With Hashimato	N/A
Not yet recruiting	`NCT05334771` - Early Detection of Endolymphatic Hydrops in Hypothyroid Patients
Withdrawn	`NCT01707056` - The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma	N/A
Completed	`NCT00094237` - Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke	N/A
Recruiting	`NCT06015620` - Comorbidities Resolution After MGB Surgery and Change in Body Composition
Completed	`NCT03612908` - TSHβX1 and D2 THR92ALA in Pregnancy
Completed	`NCT04782856` - Energy Metabolism in Thyroidectomized Patients	Phase 2
Completed	`NCT01921452` - Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit	Phase 4
Completed	`NCT01197183` - Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France	N/A
Recruiting	`NCT05247476` - Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.	Phase 4
Recruiting	`NCT03754621` - Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey
Completed	`NCT02959827` - Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
Completed	`NCT04124705` - A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants	Phase 2
Withdrawn	`NCT02577367` - Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding	Phase 4
Completed	`NCT04098991` - Improving White Matter Integrity With Thyroid Hormone
Not yet recruiting	`NCT03257566` - Hypothyroidism in Patients With Type 1 Diabetes	N/A
Terminated	`NCT02567877` - Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?
Completed	`NCT02280330` - Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months	Phase 4
Completed	`NCT00403390` - Generic vs. Name-Brand Levothyroxine	N/A
Not yet recruiting	`NCT06096454` - Effect of Life Style Modification and Metformin on Hypothyroidism With Insulin Resistance	Phase 4